Center devoted to HIV, STD, TB, and hepatitis prevention and control, and the budget document also reveals over $64 million in other resources across other CDC organization units. These other HIV-specific activities include $1.026 million for HIV/AIDS questions on the Behavioral Risk Factor Surveillance System; $41.852 million for HIV-related School Health programs; $3.423 million for HIV-related BSafe Motherhood^activities; $0.448 million for HIV-related oral health work; and $17.304 million in HIV-related hemophilia activities. Hence, the Center charged with HIV prevention at CDC has about $652 million to work with in FY07, but CDC as an agency has a total of just more than $716 million in domestic HIVspecific resources in FY07.
So, is the pool of resources shrinking or expanding over time? Recently, Holtgrave and Kates examined the correlation over time of CDC_s HIV prevention budget and HIV incidence in the U.S. 7 They adjusted CDC_s budget for inflation by using the Consumer Price Index as calculated for each federal fiscal year. Included in their paper in tabular form was CDC_s HIV prevention budget for FY81 to FY06 expressed in nominal dollars (as allocated by Congress), real dollars (adjusted for inflation to FY83 dollars), and annual percentage changes in budget. Here, we update their CPI adjustment for FY06 (as new CPI data have since become available) and add FY07 nominal and real budgetary information (nominal values are described in the paragraph above); the nominal and real HIV prevention budgets through FY07 are shown graphically here in Figure 1 .
It is immediately clear from Figure 1 that there is a contraction in the purchasing power of CDC_s HIV prevention budget. Before FY03, there had never been a budgetary decrease 2 years in a row, and only 3 years of decrease in total (however, many of the annual increases were clearly modest in real dollar terms and funding has been rather Bflat^since the early 1990s). Now, FY07 marks the fifth year in a row that the CDC_s HIV prevention budget has shrunk in real dollar terms (and the fourth year in a row in nominal terms). The average annual decrease during the last five fiscal years has been 4.15%, and there has been a 19.3% $-$100,000,000 $200,000,000 $300,000,000 $400,000,000 $500,000,000 $600,000,000 $700,000,000 $800,000,000 $900,000,000 1 9 8 1 1 9 8 2 1 9 8 3 1 9 8 4 1 9 8 5 1 9 8 6 1 9 8 7 1 9 8 8 1 9 8 9 1 9 9 0 1 9 9 1 1 9 9 2 1 9 9 3 1 9 9 4 1 9 9 5 1 9 9 6 1 9 9 7 1 9 9 8 1 9 9 9 2 0 0 0 2 0 0 1 2 0 0 2 2 0 0 3 2 0 0 4 2 0 0 5 2 0 0 6 2 0 0 7
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Unadjusted Inflation Adjusted decrease between FY02 and FY07. This figure is just slightly larger than CDC_s adjustment for inflation between FY01 and FY07, which used a different inflation index that focuses on research activities. We also observe that the purchasing power of CDC_s HIV prevention budget has not been this low since FY93. It is troubling that in a time when the epidemic continues to progress in the U.S., nearly 1 in 5 federal HIV prevention dollars (in real dollar terms) has been taken away over a five-fiscal-year period. During this time frame, President Bush put forward several nominally Bflat^budgets for domestic HIV prevention, but in FY07 included a proposal for a $93 million increase in targeted voluntary counseling and testing (VCT) programs. 8 This $93 million Presidential proposal, however, was not passed by Congress. Still, CDC has indicated to Congress that it is attempting internally to identify $45 million in additional resources for HIV testing in FY07. 9 Whereas this is an encouraging sign, we have not yet included this amount in our analysis for the following reasons: (a) the source of this redirected $45 million in CDC_s budget has not yet been made public (i.e., which public health program is Bpaying for^this potential redirection is not clear); (b) the exact details of the possible uses for the $45 million are not yet known; (c) at this point, it would appear that this potential redirection would be a one-time investment (not an ongoing Congressional appropriation).
It is worth noting that some of the nominal decrease between FY03 and FY04 reflects a new budget structure at CDC in which administrative and management costs at the agency level (purportedly in support of HIV/AIDS activities) were removed permanently from the HIV/AIDS budget and transferred to an administrative budget line. 10 We might ask whether CDC_s budget contraction is being compensated for by increases in prevention funds in the Minority AIDS Initiative (MAI; this Initiative began in FY99 as an urgent attempt by Congress to direct new monies toward HIV prevention, treatment, and related services in communities of color disproportionately impacted by the epidemic). Unfortunately, the Minority AIDS Initiative is not compensating for CDC_s HIV/AIDS budget contraction. CDC_s Bshare^of the Minority AIDS Initiative funds are already contained in CDC_s budget (with the possible exception of a relatively small amount of MAI funding from the Secretary of Health and Human Services_ Minority Communities Fund of approximately $50 million, which can be allocated across the Department_s agencies including CDC). 11 In fact, the Minority AIDS Initiative across the Department of Health and Human Services is now also contracting in real dollar terms (please see Figure 2 , which graphs MAI funding levels obtained from the Kaiser Family Foundation and Congressional Research Service, and converts them to real dollar terms). 10, 11, 12 There are also small amounts of HIV prevention resources in other federal agencies, but CDC and the Minority AIDS Initiative account for the bulk of the federal HIV prevention funding.
So what needs to be done to address the situation (at least in part)? If we begin with an FY07 estimated budget of $716 million, an additional $171 million would be needed simply to get back to the purchasing power of the FY02 budget ($887 million in total); that would undo the damage of nominal dollar cuts, CDC_s budget restructuring, and the effects of inflation.
The literature contains estimates of the cost of unmet HIV prevention needs in the U.S. 13 Expressed here in FY07 dollars, it has been estimated that an additional $434 million (above FY02 budget levels) would be needed each year for 4 years to provide HIV prevention services to those now unserved or underserved. 13 This means that to both address the contraction of the HIV prevention budget and provide resources to address unmet needs, CDC_s HIV prevention should be in the order of $1.321 billion.
If such an investment were made it would be cost-saving to the U.S. as a society if it could avert 22,094 of the expected 160,000 new HIV infections over the next 4 years. This statement assumes that without the programmatic expansion the current 40,000 HIV infections per year might continue in the U.S., 14 and that the net present value of HIV treatment over a lifetime is $239,253 (though the literature suggests it might be even higher than this value). 15, 16 Such a threshold would appear highly achievable.
In conclusion, we see that CDC_s new Bheightened^response to HIV prevention in African American communities comes at a time when almost 1 dollar in 5 has been removed from HIV prevention efforts over the last 5 fiscal years (in real dollar terms). The reasons for this contraction would appear to be caused by a myriad of factors possibly including political will (and interest in abstinence-only programs), budget restructuring at CDC, HIV complacency, misperceptions of HIV prevention effectiveness, stigma, and discrimination; what the precise set of reasons might be could be the subject of lengthy and legitimate debate.
What is known with more certainty is that there appears to be an inverse correlational relationship between HIV prevention funding levels and HIV incidence, 7 and therefore this budgetary contraction comes with public health peril. At least bringing the HIV prevention budget back to its FY02 real dollar value, and on top of that, addressing unmet HIV prevention needs are critical to truly bring down HIV incidence in the US and address health disparities in a highly impactful way. Sadly, at this moment, Bheightened^appears to mean Blessened^in our national budgetary lexicon.
We believe that continued analyses of this type are needed to track inflationadjusted trends in public health expenditures, elucidate estimates of unmet needs, and utilize threshold analyses to set performance standards. Such ongoing analyses are needed not only in HIV/AIDS, but in all areas of public health.
